Could Sorrento Therapeutics Be a Millionaire-Maker Stock?
Sorrento Therapeutics (NASDAQ: SRNE) has gone all in when it comes to coronavirus work. The biotech company has 10 potential coronavirus products in the pipeline, including diagnostics, treatments, and prevention. With such a portfolio of possibilities, we might wonder if Sorrento is the coronavirus stock to buy.
Other companies working in the coronavirus space have surely made some millionaires in the past months. For example, Moderna and Novavax soared more than 354% and more than 2,100%, respectively, this year. Before we decide whether Sorrento may follow in their footsteps, let’s have a look at the company’s progress so far and the rest of its pipeline.